Challenging the believed proportion of ovarian cancer attributable to BRCA2 versus BRCA1 pathogenic variants
Affiliation
Division of Evolution and Genomic Sciences, School of Biological Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester Academic Health Science Centre, Manchester, M13 9PLIssue Date
2019
Metadata
Show full item recordCitation
Flaum N, Crosbie EJ, Woodward ER, Lalloo F, Gareth Evans D. Challenging the believed proportion of ovarian cancer attributable to BRCA2 versus BRCA1 pathogenic variants. Eur J Cancer. 2020;124:88-90.Journal
European journal of cancerDOI
10.1016/j.ejca.2019.10.018PubMed ID
31760313Additional Links
https://dx.doi.org/10.1016/j.ejca.2019.10.018Type
ArticleLanguage
enae974a485f413a2113503eed53cd6c53
10.1016/j.ejca.2019.10.018